Literature DB >> 7981052

Characterisation of tumour blood flow using a 'tissue-isolated' preparation.

G M Tozer1, K M Shaffi, V E Prise, V J Cunningham.   

Abstract

Tumour blood flow was characterised in a 'tissue-isolated' rat tumour model, in which the vascular supply is derived from a single artery and vein. Tumours were perfused in situ and blood flow was calculated from simultaneous measurement of (1) venous outflow from the tumour and (2) uptake into the tumour of radiolabelled iodo-antipyrine (IAP). Comparison of results from the two measurements enabled assessment of the amount of blood 'shunted' through the tumours with minimal exchange between blood and tissue. Kinetics of IAP uptake were also used to determine the apparent volume of distribution (VDapp) for the tracer and the equilibrium tissue-blood partition coefficient (lambda). lambda was also measured by in vitro techniques and checks were made for binding and metabolism of IAP using high-pressure liquid chromatography. VDapp and lambda were used to calculate the perfused fraction (alpha) of the tumours. Tumour blood flow, as measured by IAP (TBFIAP), was 94.8 +/- 4.4% of the blood flow as measured by venous outflow, indicating only a small amount of non-exchanging flow. This level of shunting is lower than some previous estimates in which the percentage tumour entrapment of microspheres was used. The unperfused fraction ranged from 0 to 20% of the tumour volume in the majority of tumours. This could be due to tumour necrosis and/or acutely ischaemic tumour regions. For practical purposes, measurement of the total venous outflow of tumours is a reasonable measure of exchangeable tumour blood flow in this system and allows for on-line measurements. Tracer methods can be used to obtain additional information on the distribution of blood flow within tumours.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7981052      PMCID: PMC2033701          DOI: 10.1038/bjc.1994.445

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  25 in total

1.  Tumor blood flow and systemic shunting in patients receiving intraarterial chemotherapy for head and neck cancer.

Authors:  R H Wheeler; H A Ziessman; B R Medvec; J E Juni; J H Thrall; J W Keyes; S R Pitt; S R Baker
Journal:  Cancer Res       Date:  1986-08       Impact factor: 12.701

Review 2.  Vascularization of tumors: a review.

Authors:  P Shubik
Journal:  J Cancer Res Clin Oncol       Date:  1982       Impact factor: 4.553

3.  The vascular pattern of the spontaneous C3H mouse mammary carcinoma and its significance in radiation response and in hyperthermia.

Authors:  P Falk
Journal:  Eur J Cancer       Date:  1980-02       Impact factor: 9.162

4.  Microcirculation of tumors. I. Anatomy, function, and necrosis.

Authors:  P Rubin; G Casarett
Journal:  Clin Radiol       Date:  1966-07       Impact factor: 2.350

Review 5.  Tumor angiogenesis.

Authors:  J Folkman
Journal:  Adv Cancer Res       Date:  1985       Impact factor: 6.242

6.  Microcirculatory blood flow, capillary morphology and local oxygen pressure of the hamster amelanotic melanoma A-Mel-3.

Authors:  B Endrich; F Hammersen; A Götz; K Messmer
Journal:  J Natl Cancer Inst       Date:  1982-03       Impact factor: 13.506

7.  Intermittent blood flow in a murine tumor: radiobiological effects.

Authors:  D J Chaplin; P L Olive; R E Durand
Journal:  Cancer Res       Date:  1987-01-15       Impact factor: 12.701

8.  Measurement of local cerebral blood flow with iodo [14C] antipyrine.

Authors:  O Sakurada; C Kennedy; J Jehle; J D Brown; G L Carbin; L Sokoloff
Journal:  Am J Physiol       Date:  1978-01

9.  Studies on the exchange of fluids between host and tumor. II. The blood flow of hepatomas and other tumors in rats and mice.

Authors:  P M GULLINO; F H GRANTHAM
Journal:  J Natl Cancer Inst       Date:  1961-12       Impact factor: 13.506

10.  Error analysis of a quantitative cerebral blood flow measurement using H2(15)O autoradiography and positron emission tomography, with respect to the dispersion of the input function.

Authors:  H Iida; I Kanno; S Miura; M Murakami; K Takahashi; K Uemura
Journal:  J Cereb Blood Flow Metab       Date:  1986-10       Impact factor: 6.200

View more
  7 in total

1.  Tumour blood flow modification by endothelin-related peptides in the rat HSN fibrosarcoma.

Authors:  K M Bell; V E Prise; D J Chaplin; G M Tozer
Journal:  Br J Cancer Suppl       Date:  1996-07

2.  Reduced capacity of tumour blood vessels to produce endothelium-derived relaxing factor: significance for blood flow modification.

Authors:  G M Tozer; V E Prise; K M Bell; M F Dennis; M R Stratford; D J Chaplin
Journal:  Br J Cancer       Date:  1996-12       Impact factor: 7.640

3.  The endothelin B (ETB) receptor agonist IRL 1620 is highly vasoconstrictive in two syngeneic rat tumour lines: potential for selective tumour blood flow modification.

Authors:  M Cemazar; I Wilson; V E Prise; K M Bell; S A Hill; G M Tozer
Journal:  Br J Cancer       Date:  2005-07-11       Impact factor: 7.640

4.  Enhanced tumour specificity of an anti-carcinoembrionic antigen Fab' fragment by poly(ethylene glycol) (PEG) modification.

Authors:  C Delgado; R B Pedley; A Herraez; R Boden; J A Boden; P A Keep; K A Chester; D Fisher; R H Begent; G E Francis
Journal:  Br J Cancer       Date:  1996-01       Impact factor: 7.640

5.  The response of tumour vasculature to angiotensin II revealed by its systemic and local administration to 'tissue-isolated' tumours.

Authors:  G M Tozer; K M Shaffi
Journal:  Br J Cancer       Date:  1995-09       Impact factor: 7.640

Review 6.  Overview of Methods for Overcoming Hindrance to Drug Delivery to Tumors, with Special Attention to Tumor Interstitial Fluid.

Authors:  Gianfranco Baronzio; Gurdev Parmar; Miriam Baronzio
Journal:  Front Oncol       Date:  2015-07-23       Impact factor: 6.244

7.  Direct arterial injection of hyperpolarized 13 C-labeled substrates into rat tumors for rapid MR detection of metabolism with minimal substrate dilution.

Authors:  Steven Reynolds; Stephen Metcalf; Edward J Cochrane; Rebecca C Collins; Simon Jones; Martyn N J Paley; Gillian M Tozer
Journal:  Magn Reson Med       Date:  2017-02-12       Impact factor: 4.668

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.